ARCHIVES

Vanderbilt-Ingram wins third SPORE grant.

This article is from The Cancer Letter archive.

Vol. 29 No. 34 | September 19, 2003

Download PDF Visit The Full Archive

Related Articles

Modality Combo Decreases Prostate Cancer Recurrence

August 27, 2004

Chemical Carcinogenesis

November 18, 1994

MUSC Hollings Cancer Center awarded NCI designation

February 1, 2021

Alimta Granted Approval As NSCLC Continuation Therapy

November 25, 2011

FDA News: Rep. Barton Expresses “Concern” About Plan To Merge Offices

May 22, 1998

NCI Clinical Trials Enrollment Drops to 17,500

February 21, 2014